Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging

Bibliography

• Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011;31:27-33
   PubMed Web of Science ®Google Scholar
• Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010;77:502-14
   PubMed Web of Science ®Google Scholar
• Tushuizen ME, Diamant M, Sturk A, Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscler Thromb Vasc Biol 2011;31:4-9
   PubMed Web of Science ®Google Scholar
• Nomura S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009;5:245-51
   Google Scholar
• Morel O, Jesel L, Freyssinet JM, Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011;31:15-26
   PubMed Web of Science ®Google Scholar
• Ratajczak J, Miekus K, Kucia M, Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006;20:847-56
   PubMed Web of Science ®Google Scholar
• Chironi GN, Boulanger CM, Simon A, Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143-51
   PubMed Web of Science ®Google Scholar
• Rautou PE, Vion AC, Amabile N, Microparticles, vascular function, and atherothrombosis. Circ Res 2011;109:593-606
   PubMed Web of Science ®Google Scholar
• Curtis AM, Wilkinson PF, Gui M, p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. J Thromb Haemost 2009;7:701-9
   PubMed Web of Science ®Google Scholar
• Sapet C, Simoncini S, Loriod B, Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006;108:1868-76
   PubMed Web of Science ®Google Scholar
• Simoncini S, Njock MS, Robert S, TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. Circ Res 2009;104:943-51
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Anfosso F, Lacroix R, Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010;104:456-63
   Google Scholar
• Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003;44:233-42
   PubMed Web of Science ®Google Scholar
• Sekuła M, Janawa G, Stankiewicz E, Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro. Cell Mol Biol Lett 2011;16:69-78
   Google Scholar
• Kim HK, Song KS, Chung JH, Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124:376-84
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V, Clancy JW, Sedgwick A, Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010;123:1603-11
   PubMed Web of Science ®Google Scholar
• Stepien E, Gruca A, Grzybowska J, Different population of platelet derived microparticles from healthy donors stimulate angiogenesis in vitro. Cardiovasc Res 2012;93(Suppl):S75
   Google Scholar
• Dainiak N, Riordan MA, Strauss PR, Contractile proteins participate in release of erythroid growth regulators from mononuclear cells. Blood 1988;72:165-71
   Google Scholar
• Cauwenberghs S, Feijge MA, Harper AG, Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006;580:5313-20
   PubMed Web of Science ®Google Scholar
• Manno S, Takakuwa Y, Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci USA 2002;99:1943-8
   PubMed Web of Science ®Google Scholar
• Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047-57
   PubMed Web of Science ®Google Scholar
• Czyz J, Szpak K, Madeja Z. The role of connexins in prostate cancer promotion and progression. Nat Rev Urol 2012;9:274-82
   Google Scholar
• Stepien E. Acceleration of new biomarkers development and discovery in synergistic diagnostics of coronary artery disease, coronary angiography - advances in noninvasive imaging approach for evaluation of coronary artery disease. In: Baskot B, editor. InTech; 2011. Available from: http://www.intechopen.com
   Google Scholar
• Jimenez JJ, Jy W, Mauro L, Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175-80
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Majka M, Kijowski J, Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001;98:3143-9
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Lawson JA, Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997;99:2118-27
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Willeit P, Tilling L, Prospective study on circulating microRNAs and risk of myocardial infarction. Cardiovasc Res 2012;93(Suppl):S43
   Google Scholar
• Hunter MP, Ismail N, Zhang X, Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694
   PubMed Web of Science ®Google Scholar
• Raitoharju E, Lyytikainen LP, Levula M, miR-21, miR-210,miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011;219:211-17
   PubMed Web of Science ®Google Scholar
• Mezentsev A, Merks RMH, O'Riordan E, Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005;289:H1106-14
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Rautou PE, Silvestre JS, CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 2008;52:1302-11
   PubMed Web of Science ®Google Scholar
• Gordon EM, Venkatesan N, Salazar R, Factor XII-induced mitogenesis is mediated via a distinctsignal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci USA 1996;93:2174-9
   Google Scholar
• Zhou H, Shi W, Zhou B, Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation. Mol Med Rep 2010;3:269-74
   Web of Science ®Google Scholar
• Diamant M, Nieuwland R, Pablo RF, Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002;106:2442-7
   PubMed Web of Science ®Google Scholar
• Tsimerman G, Roguin A, Bachar A, Involvement of microparticles in diabetic vascular complications. Thromb Haemost 2011;106:310-21
   PubMed Web of Science ®Google Scholar
• Hjortoe GM, Petersen LC, Albrektsen T. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004;103:3029-37
   PubMed Web of Science ®Google Scholar
• Chahed S, Leroyer AS, Benzerroug M, Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes 2010;59:694-701
   Google Scholar
• Rao VR, Prescott E, Shelke NB, Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci 2010;51:5198-204
   PubMed Web of Science ®Google Scholar
• McArthur K, Feng B, Wu Y, MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011;60:1314-23
   PubMed Web of Science ®Google Scholar
• Silva VA, Polesskaya A, Sousa TA, Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol Vis 2011;17:2228-40
   PubMed Web of Science ®Google Scholar
• Staszel T, Zapała B, Polus A, Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 2011;121:361-6
   PubMed Web of Science ®Google Scholar
• Lacroix R, Robert S, Poncelet P, Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010;8:2571-4
   PubMed Web of Science ®Google Scholar
• Morel O, Morel N, Jesel L, Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011;33:469-86
   PubMed Web of Science ®Google Scholar
• Wang JM, Yang Z, Xu MG, Berberine-induced decline in circulationg CD31+/CD42- microparticles is associated with improvement of endothelial function in humans. Eur J Pharmacol 2009;614:77-83
   PubMed Web of Science ®Google Scholar
• Cheng F, Wang Y, Li J, Berberine improves endothelial function be reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol 2012; In press
   Google Scholar
• Nomura S, Suzuki M, Katsura K, Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995;116:235-40
   PubMed Web of Science ®Google Scholar
• Koga H, Sugiyama S, Kugiyama K, Elevated levels of VE-cadherin-positive endothelial microparticles inpatients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005;45:1622-30
   PubMed Web of Science ®Google Scholar
• Tan KT, Tayebjee HM, Lim HS. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med 2005;22:1657-62
   PubMed Web of Science ®Google Scholar
• Bulut D, Maier K, Bulut-Streich N, Circulating endothelial microparticles corretate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 2008;14:336-40
   PubMed Web of Science ®Google Scholar
• Bulut D, Tuns H, Mugge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest 2009;39:17-22
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Heresi GA, Velasquez H, Elevation of endothelial microparticles,platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45:1467-71
   PubMed Web of Science ®Google Scholar
• Bal L, Ederhy S, Di Angelantonio E, Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch Cardiovasc Dis 2010;103:394-403
   PubMedGoogle Scholar
• Bal L, Ederhy S, Di Angelantonio E, Circulationg procoagulant microparticles in acute pulmonary embolism; a case-control study. Int J Cardiol 2010;145:321-2
   Google Scholar
• Garcia Rodriguez P, Eikenboom HC, Tesselaar ME, Plasma levels of microparticle-associated tissues factor activity in patients with clinically suspected pulmonary embolism. Thromb Res 2010;126:345-9
   PubMedGoogle Scholar
• Steppich BA, Hassenpflug M, Braun SL, Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis. Vasa 2011;40:117-22
   PubMedGoogle Scholar
• Campello E, Spiezia L, Radu CM, Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res 2011;127:473-7
   PubMed Web of Science ®Google Scholar
• Morel O, Hugel B, Jesel L, Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004;91:345-53
   PubMedGoogle Scholar
• van der Zee PM, Biro E, Ko Y, P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006;52:657-64
   PubMed Web of Science ®Google Scholar
• Stepien E, Stankiewicz E, Zalewski J, Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res 2012;43:31-5
   PubMed Web of Science ®Google Scholar
• Preston RA, Jy W, Jimenez JJ, Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003;41:211-17
   PubMed Web of Science ®Google Scholar
• Wang JM, Su C, Wang Y, Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens 2009;23:307-15
   PubMed Web of Science ®Google Scholar
• Amabile N, Heiss C, Real WM, Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1268-75
   PubMed Web of Science ®Google Scholar
• Diehl P, Aleker M, Helbing T, Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension. J Thromb Thrombolysis 2011;31:173-9
   PubMed Web of Science ®Google Scholar
• Simak J, Gelderman MP, Yu H, Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-302
   PubMed Web of Science ®Google Scholar
• Jung K-H, Chu K, Lee S-T, Circulatig endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol 2009;66:191-9
   PubMed Web of Science ®Google Scholar
• Kuriyama N, Nagakane Y, Hosomi A, Evaluation factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clin Appl Thromb Hemost 2010;16:26-32
   PubMed Web of Science ®Google Scholar
• Łukasik M, Rozalski M, Luzak B, Platelet activation and reactivity in the convalescent phase of ischemic stroke. Thromb Haemost 2010;103:644-50
   PubMed Web of Science ®Google Scholar
• Lackner P, Dietmann A, Beer R, Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke 2010;41:2353-7
   Google Scholar
• Amabile N, Guerin AP, Leroyer A, Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-8
   PubMed Web of Science ®Google Scholar
• Faure V, Dou L, Sabatier F, Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006;4:566-73
   PubMed Web of Science ®Google Scholar
• Daniel L, Fakhouri F, Joly D, Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006;69:1416-23
   PubMed Web of Science ®Google Scholar
• Dursun I, Poyrazoglu HM, Gunduz Z, The relationship between circulating endothelial microparticles and arterial stiffness and atheosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 2009;24:2511-18
   PubMed Web of Science ®Google Scholar
• Huang PH, Huang SS, Chen YH, Increased circulating CD31+/annexin V+ apoptotic microaprticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens 2010;28:1655-65
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Litwiller R, Owen WG, Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008;295:H931-8
   PubMed Web of Science ®Google Scholar
• Stepien E, Stolinski J, Grzybowska J, Potential role of platelet derived microparticles and their aggregates in atherosclerotic plaque vascularization. Cardiovasc Res 2012;93(Suppl):S76
   Google Scholar
• Fortunato O, Caporali A, Sangalli E, MicroRNA-15a and mir-16 regulate sdf-1 migration of endothelial progenitor cells in diabetic patients with limb ischemia and healthy controls. Cardiovasc Res 2012;93(Suppl):S34
   Google Scholar
• Maegdefessel L, Azuma J, Toh R, MicroRNAs -21 and -29b regulate abdominal aortic aneurysm expansion. Cardiovasc Res 2012;93(Suppl):S83
   Google Scholar
• Gambacciani C, Chiavacci E, Evangelista M, miR-29 and miR-30 are involved in cardiac epigenetic reprogramming after myocardial infarction and ischemia. Cardiovasc Res 2012;93(Suppl):S54
   Google Scholar
• De Pauw A, Sekkali B, Friart A, Inhibition of endogenous Wnt/beta-catenin following miR29a downregulation mediates differentiation of Cardiac Stem Cells into cardiomyocytes. Cardiovasc Res 2012;93(Suppl):S99
   Google Scholar
• Zhang H. Sweeney D,Thomas GN, et al. The role of miR-29b/collagen Type I/BMP-1 pathway in angiogenesis in the ischaemic human heart. Cardiovasc Res 2012;93(Suppl):S76
   Google Scholar
• Zernecke A, Bidzhekov K, Noels H, Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81
   PubMed Web of Science ®Google Scholar
• Costa M, Cortez-Dias N. Carrilho-Ferreira P, et al. miR-375: novel biomarker for early prognostic stratification of acute myocardial infarction. Cardiovasc Res 2012;93(Suppl):S11
   Google Scholar